Education
About Us
Working with TipRanks
Follow Us
PolyPeptide Group AG (CH:PPGN)
:PPGN
Total Valuation
PolyPeptide Group AG has a market cap or net worth of CHF476.31M. The enterprise value is CHF961.35M.
Market CapCHF476.31M
Enterprise ValueCHF961.35M
Share Statistics
PolyPeptide Group AG has 33.13M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33.13M
Owened by Insiders
Owened by Instutions
Financial Efficiency
PolyPeptide Group AG’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -1.33%.
Return on Equity (ROE)-5.48%
Return on Assets (ROA)-2.59%
Return on Invested Capital (ROIC)-1.33%
Return on Capital Employed (ROCE)-1.31%
Revenue Per EmployeeCHF235,221.733
Profits Per Employee-CHF37,767.988
Employee Count1,362
Asset Turnover0.45
Inventory Turnover2.05
Valuation Ratios
The current PE Ratio of PolyPeptide Group AG is -50.85. PolyPeptide Group AG’s PEG ratio is 0.82.
PE Ratio-50.85
PS Ratio2.94
PB Ratio2.78
Price to Fair Value2.78
Price to FCF409.26
Price to Operating Cash Flow11.13
PEG Ratio0.82
Income Statement
In the last 12 months, PolyPeptide Group AG had revenue of CHF320.37M and earned -CHF51.44M in profits. Earnings per share was -CHF1.56.
RevenueCHF320.37M
Gross ProfitCHF4.77M
Operating Income-CHF33.83M
Pretax Income-CHF58.24M
Net Income-CHF51.44M
EBITDA-12.31M
Earnings Per Share (EPS)-1.56
Cash Flow
In the last 12 months, operating cash flow was CHF36.48M and capital expenditures -CHF52.90M, giving a free cash flow of -CHF16.41M billion.
Operating Cash FlowCHF36.48M
Free Cash Flow-CHF16.41M
Free Cash Flow per Share-CHF0.50
Dividends & Yields
PolyPeptide Group AG pays an annual dividend of CHF0.30, resulting in a dividend yield of
Dividend Per ShareCHF0.30
Dividend Yield
Payout Ratio
Free Cash Flow Yield0.24%
Earnings Yield-1.97%
Stock Price Statistics
Beta1.19
52-Week Price Change-49.90%
50-Day Moving Average19.39
200-Day Moving Average27.02
Relative Strength Index (RSI)34.87
Average Volume (3m)89.92K
Important Dates
PolyPeptide Group AG upcoming earnings date is Aug 12, 2025, Before Open.
Last Earnings DateMar 11, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend DateApr 28, 2022
Financial Position
PolyPeptide Group AG as a current ratio of 1.69, with Debt / Equity ratio of 0.26
Current Ratio1.69
Quick Ratio0.94
Debt to Market Cap0.07
Net Debt to EBITDA0.91
Interest Coverage Ratio-0.53
Taxes
In the past 12 months, PolyPeptide Group AG has paid CHF6.80M in taxes.
Income TaxCHF6.80M
Effective Tax Rate-7.82%
Enterprise Valuation
PolyPeptide Group AG EV to EBITDA ratio is 35.92, with an EV/FCF ratio of 419.89.
EV to Sales3.01
EV to EBITDA35.92
EV to Free Cash Flow419.89
EV to Operating Cash Flow11.42
Balance Sheet
PolyPeptide Group AG has CHF95.71M in cash and marketable securities with CHF113.66M in debt, giving a net cash position of CHF17.96M billion.
Cash & Marketable SecuritiesCHF95.71M
Total DebtCHF113.66M
Net CashCHF17.96M
Net Cash Per ShareCHF0.54
Tangible Book Value Per ShareCHF10.39
Margins
Gross margin is 11.59%, with operating margin of -2.17%, and net profit margin of -5.78%.
Gross Margin11.59%
Operating Margin-2.17%
Pretax Margin-5.36%
Net Profit Margin-5.78%
EBITDA Margin8.39%
EBIT Margin-1.27%
Analyst Forecast
The average price target for PolyPeptide Group AG is CHF33.33, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF33.33
Price Target Upside131.78%
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast
EPS Growth Forecast